PDS Biotechnology's Option/Warrant Round

PDS Biotechnology raised a round of funding on December 16, 2016. Investors include NetScientific.

PDS Biotechnology is a clinical stage biopharmaceutical company developing simpler, safer and more effective immunotherapies for cancer and infectious disease. PDS Biotechnology has developed a novel …

Articles about PDS Biotechnology's Option/Warrant Round: